Comparative Effects of Garlic and Aspirin on Diabetic Cardiovascular Complications

References

• Factor, S. M., Minase, T., and Sonneblick, E. H. 1980. Clinical and morpho- logical features of human hypertensive diabetic cardiomyopathy. Am. Heart J. 99:447–458.
   Google Scholar
• Gotzsche, O. 1986. Myocardial cell dysfunction in diabetes mellitus. A review of clinical and experimental studies. Diabetes 35:1158–1162.
   PubMed Web of Science ®Google Scholar
• Labadini, Z. D., and Gold, D. E. 1983. High prevalence of echocardiograp h abnormalities in diabetic youths. Diabetes Care 6:18–22.
   PubMed Web of Science ®Google Scholar
• Micheal, J. A., and Richard, G. L. 1989. Alterations in distribution of cardiac output in experimental diabetes in rats. Am. J. Physiol. 257:H571–H580.
   Google Scholar
• Thomas, B. M. 1979. Cardiac performance of isolated perfused hearts from alloxan diabetic rats. Am. J. Physiol. 236(6):H800–H812.
   Google Scholar
• Crall, F. V., and Robert, W. C. 1978. The extramural and intramural coronary arteries in juvenile diabetes melitus: analysis of diabetes before age 15 years. Am. J. Med. 64:221–230.
   PubMed Web of Science ®Google Scholar
• Patumraj, S., Kasantikul, V., Tewit, S., and Sermpakdeekul, P. 1997. The study of garlic extract on diabetic cardiovascula r complications. Microcir- culation Annual 13:31–34.
   Google Scholar
• Patumraj, S., Jetapai, U., and Udayachalerm, W. 1996. Prevention of diabetic cardiovascula r complications by garlic extract. Excerpta Medica 12:107–116.
   Google Scholar
• Patumraj, S., Tewit, S., Kasantikul, V., and Udayachalerm, W. 1997. Effect of garlic extract on plasma insulin, lipid profiles and coronary vascular changes in STZ-rats. In Sixth World Congress for Micro., 977–982. Bologna, Italy: Monduzzi Editore S.p.A.
   Google Scholar
• Patumraj, S., Pongpradist, K., and Udayachalerm, W. 1994. Effect of garlic extract on plasma fibrinogen, fibrinogen, fibrinolytic activity, and cardiovas- cular complications in diabetic rats. Third Congress of Federation of Asian and Ocenian Physiological Societies. Nov. 7–10, 1994, Shanghai, China.
   Google Scholar
• Tewit, S., Patumraj, S., Maneesri, S., and Kasantikul, V. 1998. Microcir- culatory aspects of Asian traditional medicine, 117–128. Bologna, Italy: Monduzzi Ediotore, S.p.A.
   Google Scholar
• Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarto Miocardico. 1986. Effectiveness of intravenous thrombolyti c treatment in acute myocar- dial infarction. Lancet 1:397–402.
   PubMed Web of Science ®Google Scholar
• ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. 1988. Randomised trial of intravenou s streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarc- tion. Lancet 2:349–360.
   Google Scholar
• AIMS Trial Study Group. 1988. Effect of intravenou s APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlle d clinical trial. Lancet 2:545–549.
   Google Scholar
• Wilcox, R. G., von der Lippe, G., Ollson, C. G., Jensen, G., Skene, A. M., and Hampton, J. R. 1988. Trial of tissue plasminogen activation for mortal- ity reduction in acute myocardial infarction: Anglo-Scandinavia n Study of Early Thrombolysis. Lancet 2:525–530.
   PubMed Web of Science ®Google Scholar
• White, H. D., Norris, R. M., Brown, M. A., Takayama, M., Maslowski, A., Bass, N. M., Ormiston, J. A., and Whitlock, T. 1987. Effect of intra- venous streptokinase on left ventricular function and early survival after acute myocardial infarction. N. Engl. J. Med. 317:850–855.
   PubMed Web of Science ®Google Scholar
• Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. 1994. Indica-tions for fibrinolytic therapy in suspected acute myocardial infarction: col- laborative overview of early mortality and major morbidity results all ran- domized trials of more than 1000 patients. Lancet 343:311–322.
   PubMed Web of Science ®Google Scholar
• Block, E., Ahmed, S., Catlfamo, J. L., Jain, M. K., and Apitz-Castro, R. 1986. Antithrombotic organosulfu r compound s from garlic: structural, mechanistic and synthetic studies. J. Am. Chem. Soc. 108:7045–7055.
   Web of Science ®Google Scholar
• Gebhardt, R. 1993. Multiple inhibitory effects of garlic extract on choles- terol biosynthesi s in hepatocytes. Lipids 28:613.
   PubMed Web of Science ®Google Scholar
• Sendl, A., Schliack, M., Loser, R., Stanislaus, F., and Wagner, H. 1992. In- hibition of cholesterol synthesi s in vitro by extracts and isolated compound s prepared from garlic and wild garlic. Atherosclerosis 94:79.
   PubMedGoogle Scholar
• Jain, R. C., and Vyas, C. R. 1975. Garlic in alloxan-induce d diabetic rabbits. Am. J. Clin. Nutr. 28:684–685.
   PubMed Web of Science ®Google Scholar
• Pantoja, C. V., Chiang, L. C., Norris, B. C., and Concha, J. B. 1991. Diuretic, natriuretic and hypotensive effects produced by Allium sativum (garlic) in anesthetized dogs. J. Ethnopharmaco l. 31(3):325–331.
   PubMed Web of Science ®Google Scholar
• Siegel, G., Walter, A., Schnalke, F., et al. 1991. Potassium channel activation, hyperpolarization, and vascular relaxation. Z. Kardiol. 80:9.
   PubMedGoogle Scholar
• Siegel, G. Changes in vascular tone and calcium metabolism. Z. Phytother. 1995;Abstract:14.
   Google Scholar
• Isensee, H., Rietz, B., and Jacob, R. 1993. Cardioprotective actions of garlic (Allium sativum). Arzneimittelforschung 43(2):94–98.
   PubMed Web of Science ®Google Scholar
• Cohen, R. A. 1993. Dysfunction of vascular endothelium in diabetes mel- litus. Circulation 87(suppl. 5):67–76.
   Google Scholar
• Giugliano, D., Ceriello, A., and Paolisso, G. 1995. Diabetes mellitus, hypertension, and cardiovascula r disease: which role for oxidant stress? Metabolism 44:363–368.
   PubMed Web of Science ®Google Scholar
• Orekhov, A. N., Pivovarova, E. M., and Tertov, V. V. 1996. Gar- lic powder tablets reduce atherogenicit y of low density lipoprotein. A placebo controlled double-blin d study. Nutr. Metab. Cardiovasc. Dis. 6: 21.
   Web of Science ®Google Scholar
• Lewin, G., and Popov, I. 1994. Antioxidant effects of aqueous garlic extract 2nd communication: inhibition of the Cu(2 +)-initiated oxidation of low density lipoproteins. Arzneimittelforschung 44:604.
   PubMed Web of Science ®Google Scholar